A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)

NCT00943111 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease, Type 1

Interventions

DRUG: Eliglustat tartrate
DRUG: Imiglucerase

Sponsor

Genzyme, a Sanofi Company